SummitTX Capital »

Compass Therapeutics shares owned by SummitTX Capital

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $437k 81k 5.37

More positions owned by SummitTX Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Asml Holding N V N Y Registry Shs (ASML)
Eli Lilly & Co. (LLY)
MKS Instruments (MKSI)
Wal-Mart Stores (WMT)
Paypal Holdings (PYPL)
Applied Materials (AMAT)
Amazon (AMZN)
Anthem (ELV)
Costco Wholesale Corporation (COST)
UnitedHealth (UNH)
Meritage Homes Corporation (MTH)

View all positions for SummitTX Capital

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
BlackRock
Vanguard Group
Enavate Sciences GP
Adage Capital Partners GP
State Street Corporation
BVF
FMR
Rock Springs Capital Management
Deerfield Management Company
Geode Capital Management

View all funds holding Compass Therapeutics